AWHL (Aspira Womens Health) Ending Cash Position: $1.34 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AWHL Aspira Womens Health Inc AWHL
38 GF Score
Price $0.34
GF Value $0.27
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Aspira Womens Health Ending Cash Position?

Aspira Womens Health AWHL -2.34% 38 Ending Cash Position is $1.34 Mil as of Mar. 2026. GuruFocus rates AWHL with a GF Score™ of 38/100 and a GF Value™ of $0.27 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Aspira Womens Health's Ending Cash Position for the quarter that ended in Mar. 2026 was $1.34 Mil.

Aspira Womens Health's quarterly Ending Cash Position declined from Sep. 2025 ($3.81 Mil) to Dec. 2025 ($1.76 Mil) and declined from Dec. 2025 ($1.76 Mil) to Mar. 2026 ($1.34 Mil).

Aspira Womens Health's annual Ending Cash Position declined from Dec. 2023 ($2.86 Mil) to Dec. 2024 ($1.77 Mil) and declined from Dec. 2024 ($1.77 Mil) to Dec. 2025 ($1.76 Mil).

Aspira Womens Health Ending Cash Position Related Terms

Aspira Womens Health Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Aspira Womens Health's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspira Womens Health Ending Cash Position Chart

Aspira Womens Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.43 13.56 2.86 1.77 1.76

Aspira Womens Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.31 1.55 3.81 1.76 1.34
AWHL
38GF Score
Aspira Womens Health Inc AWHL
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspira Womens Health Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Aspira Womens Health's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.769+-0.013999999999999
=1.76

Aspira Womens Health's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.755+-0.411
=1.34

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $1.34 Mil mean?
Aspira Womens Health (AWHL) has a Ending Cash Position of $1.34 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Aspira Womens Health and its competitors.
Is Aspira Womens Health's Ending Cash Position too high?
Aspira Womens Health's current Ending Cash Position is $1.34 Mil. Overall, Aspira Womens Health has a GF Score™ of 38/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aspira Womens Health's Ending Cash Position compare to MDXH and QUCY?
Aspira Womens Health's Ending Cash Position of $1.34 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Diagnostics & Research company?
A good Ending Cash Position depends on the Medical Diagnostics & Research industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Aspira Womens Health and its competitors. Aspira Womens Health's current Ending Cash Position is $1.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspira Womens Health stock overvalued right now?
Based on GuruFocus' analysis, Aspira Womens Health (AWHL) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.27, compared to a current price of $0.34 — trading 26.6% above its estimated fair value. The current Ending Cash Position is $1.34 Mil. Aspira Womens Health's overall GF Score™ is 38/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Aspira Womens Health (AWHL), the current Ending Cash Position is $1.34 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aspira Womens Health (AWHL) Overvalued in 2026?

Based on GuruFocus' analysis, Aspira Womens Health stock appears to be overvalued. The current stock price of $0.34 is trading 26.6% above its estimated GF Value™ of $0.27. GuruFocus considers Aspira Womens Health to be Modestly Overvalued.

Key valuation signals for AWHL:

  • Ending Cash Position: $1.34 Mil
  • GF Value™: $0.27 vs. price of $0.34 (26.6% above fair value)
  • GF Score™: 38/100 with 8 warning signs

No single metric tells the full story. See the AWHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aspira Womens Health Business Description

Address 12117 Bee Caves Road, Suite 100, Building 3, Austin, TX, USA, 78738
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its main products include OvaWatch, Ova1Plus, Ova1, and Overa, which are used to assess ovarian cancer risk in women with adnexal masses. The company is also developing EndoCheck for endometriosis. The company views its operations and manages its business in a single operating segment, which is the discovery, development, and commercialization of noninvasive diagnostic tests.
38GF Score

Get the complete analysis for AWHL

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34
Price
$0.27
GF Value